Already a member?
Sign in
Manufacturing contract for world-first cancer vaccine
Source: in-PharmaTechnologist.com
Date: 03/14/06
Headline: Manufacturing contract for world-first cancer vaccine
Anticipating a US Food and Drug Administration (FDA) approval this year, Dendreon has awarded Diosynth Biotechnology with a long-term contract to supply its novel vaccine for prostate cancer – the third most common cancer in the world.
Date: 03/14/06
Headline: Manufacturing contract for world-first cancer vaccine
Anticipating a US Food and Drug Administration (FDA) approval this year, Dendreon has awarded Diosynth Biotechnology with a long-term contract to supply its novel vaccine for prostate cancer – the third most common cancer in the world.
Louise |
Latest page update: made by Louise
, Mar 15 2006, 12:31 AM EST
(about this update
About This Update
Edited by Louise
48 words added view changes - complete history) |
|
Keyword tags:
cancer vaccine
chemotherapy
prevention
Prostate cancer
research
survival
treatment
More Info: links to this page
|
